Primary study · included by 1 review

Effect of adipose tissue-derived stem cells therapy on clinical response in patients with primary Sjogren's syndrome.

Li 2023 · Li Fangfang, Lu Junhui, Shi Xinlian, et al. · Scientific reports · 2023

Included by

Treatment of Xerostomia with Mesenchymal Stem Cells - A Systematic Review and Meta-Analysis of Clinical Trials.
Non-Cochrane · intervention · 2026 · cited as Li 2023 · Results, Table 1; reference 33
Outcome this study informsPooled effectEvidenceCertainty
Unstimulated whole salivary flow rate (UWS)
Mesenchymal stem cell (MSC) injection into the salivary glands vs Placebo (saline, saline with albumin, or DMSO) · Short term (up to 6 months; time point closest to 4 months)
MD 0.06 [-0.05, 0.17]3 studies · 214 participantsGRADE not reported

1 including review in total.